Personalized combination treatment turns on an immunometabolic switch to effectively control an aggressive form of prostate cancer
Researchers at the University of Chicago Medicine Comprehensive Cancer Center established “proof-of-concept” for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.
These findings, which were published online September 18, 2023, in Clinical Cancer Research, warrant further investigation in human clinical trials, the researchers concluded.
Strategies to overcome resistance
“Prostate cancer in the metastatic ...








